Eurasian Journal of Chemical, Medicinal and Petroleum Research

Abstract Background: Hallux valgus is a common foot deformity that often leads to pain, functional impairment, and reduced quality of life. This systematic review aims to evaluate the range of motion (ROM), pain intensity, and patient satisfaction in the first six months following hallux valgus surgery.

Methods: A comprehensive search of PubMed and other relevant databases was performed to identify studies published on hallux valgus surgery outcomes. Studies were included if they assessed postoperative pain intensity, ROM, and patient satisfaction within six months. Data were extracted, and the outcomes were synthesized.

Results: Eight studies met the inclusion criteria, involving various surgical techniques, including osteotomies and joint fusions. Pain intensity decreased significantly in all studies, with Visual Analog Scale (VAS) scores improving from 7.5-8.5 preoperatively to 1.2-3.0 postoperatively. ROM showed substantial improvements, with increases of 20°-35° by the six-month follow-up. Patient satisfaction was high across studies, with most reporting scores above 80 out of 100 on the American Orthopaedic Foot and Ankle Society (AOFAS) scale.

Conclusion: Hallux valgus surgery significantly improves pain, ROM, and patient satisfaction within the first six months. These findings support the effectiveness of surgical interventions for hallux valgus in enhancing both functional outcomes and quality of life. However, further studies with larger sample sizes and long-term follow-up are necessary to confirm the sustainability of these improvements.

Abstract Background: The Systemic Immune-Inflammation Index (SII) has emerged as a reliable marker of systemic inflammation and has been associated with various postoperative outcomes in surgical patients. However, its relationship with acute postoperative pain in patients undergoing hip arthroplasty for femoral fractures remains underexplored. Objective: This study aims to investigate the correlation between the SII and acute pain intensity in patients undergoing hip arthroplasty for femoral fractures, along with its association with postoperative clinical outcomes such as length of hospital stay (LOHS), ICU admission, and platelet count.

Methods: This prospective observational study was conducted with 112 patients who underwent hip arthroplasty for femoral fractures. Preoperative blood samples were used to calculate the SII, and pain intensity was measured at various time points postoperatively using a visual analog scale (VAS). Clinical outcomes, including LOHS, ICU admissions, and platelet counts, were recorded.

Results: A significant positive correlation was found between the SII and postoperative pain intensity, with higher SII values associated with increased pain levels at 2 and 4 hours postoperatively (r = +0.745, p = 0.005). Additionally, patients with elevated SII values had significantly longer hospital stays (22 days vs. 17 days, p = 0.006), higher ICU admission rates (27.94% vs. 16.60%, p = 0.036), and elevated platelet counts. The SII was also significantly correlated with neutrophil and lymphocyte counts, highlighting its role in reflecting the inflammatory response.

Conclusion: The SII appears to be a promising predictor of postoperative pain intensity and adverse clinical outcomes in patients undergoing hip arthroplasty for femoral fractures. Elevated SII values are associated with increased pain, prolonged hospital stays, and higher rates of ICU admission. These findings suggest that the SII could serve as a useful biomarker for assessing postoperative complications and guiding clinical management in surgical patients.